Keyphrases
Pancreatic Cancer
84%
Pancreatic Ductal Adenocarcinoma
80%
Tumor
59%
Protein Kinase
57%
Tumor Immunity
57%
Mouse Model
38%
Mnk Inhibitors
35%
Human Pancreatic Ductal Adenocarcinoma
33%
Calcium Channel Blockers
28%
EP300
28%
Immune Checkpoint Inhibitors
28%
Gemcitabine Chemotherapy
28%
Pancreatic Tumorigenesis
28%
Bromodomain
28%
Optimization Evaluation
28%
Tumor Protein p53 (TP53)
28%
Oncogenesis
28%
Gemcitabine
28%
Membrane Estrogen Receptor
28%
Partial Agonist
28%
Rapamycin
28%
Tamoxifen-resistant Breast Cancer
28%
Protein Kinase C Signaling
28%
Interacting Proteins
28%
Kinase Function
28%
BET Proteins
28%
BETi
28%
Bromodomain and Extra-terminal Domain
28%
Quercetin
28%
CD8+ T Cells
28%
MEK4
28%
Macrophages
28%
Design Evaluation
28%
Antitumor Effect
28%
Design Optimization
28%
HnRNPA1
28%
Rational Design
28%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
28%
Pancreatic Adenocarcinoma
28%
Biological Evaluation
28%
Phosphorylation
28%
BET Inhibitor
28%
Human Malignancies
22%
Protein Kinase C Isoforms
21%
Cancer Cells
21%
Immune Checkpoint Blockade
19%
Tumor-associated Macrophages
17%
Pancreatic Tumor
17%
Response Predictors
16%
Combination Regimen
15%
Biochemistry, Genetics and Molecular Biology
Mouse Model
61%
Carcinogenesis
61%
Cancer Cell
57%
Immune Checkpoints
57%
Bromodomain
57%
KRAS
28%
EP300
28%
Calcium Channel Blocker
28%
Mitogen-Activated Protein Kinase
28%
Protein Kinase C
28%
Agonist
28%
Estrogen Receptor
28%
Gemcitabine
28%
Quercetin
28%
Syngenic
26%
Genetically Engineered Mouse Strain
21%
Isoform
19%
Clinical Trial
17%
Epigenetics
17%
Signal Transduction
16%
Mammalian Target of Rapamycin
14%
mTOR Signaling
14%
Slice Culture
14%
Immunity
14%
Cadherin
14%
PD-L1
9%
Murine
9%
Protein Motif
9%
CTLA-4
9%
Transcription
9%
Oncogene
9%
P38 Mitogen-Activated Protein Kinases
9%
Tumor Suppressor Protein
7%
RNA Sequence
7%
Cell Death
7%
G Protein Coupled Receptor
7%
Calmodulin
7%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Pancreas Cancer
91%
Neoplasm
49%
Immunity
40%
Breast Cancer
28%
Partial Agonist
28%
Quercetin
28%
Gemcitabine
28%
Calcium Channel Blocking Agent
28%
Mitogen-Activated Protein Kinase
28%
Immunotherapy
28%
Estrogen Receptor
28%
Tamoxifen
28%
Chemotherapy
28%
In Vitro
23%
Cancer
17%
Xenograft
16%
Isotopes of Calcium
14%
Cancer Cell
13%
Immune Checkpoint Blockade
11%
Ex Vivo
10%
Diseases
9%
Pancreatic Cancer Cell Line
9%
Prostate Cancer
9%
Division
9%
Protein Motif
9%
Clinical Trial
8%
Treatment Response
7%
RNA Sequence
7%
Antiapoptotic
7%
Calmodulin
7%
Programmed Death-Ligand 1
5%
CTLA-4
5%
Organoid
5%
Cancer Types
5%